Ulcerative ileitis after proctocolectomy in children: a complication of ulcerative colitis or a disease in itself

Alba Sánchez-Galán1, Ane M Andres1, Beatriz Fernández-Caamaño2

  • 1Department of Pediatric Surgery, Universitary Hospital La Paz, Madrid, Spain.

Insights

Ulcerative ileitis (UI) is a rare complication after restorative proctocolectomy (RPC). This study found UI occurs in children with various conditions, not just ulcerative colitis, and effective medical treatments are lacking, with diversion being a key intervention.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Inflammatory Bowel Disease

Background:

  • Ulcerative ileitis (UI) is a rare inflammation of the terminal ileum following restorative proctocolectomy (RPC) and ileoanal pullthrough procedures (IAPP).
  • While primarily associated with ulcerative colitis (UC) as prepouch ileitis, its occurrence and characteristics in children with other conditions are less understood.
  • Existing treatments for UI are often ineffective, leading to significant morbidity and reduced quality of life.

Purpose of the Study:

  • To review and summarize the clinical features and management of ulcerative ileitis (UI) in pediatric patients at our institution.
  • To investigate the association of UI with different underlying conditions beyond ulcerative colitis (UC).
  • To evaluate the effectiveness of various treatment strategies for UI in children.

Main Methods:

  • A descriptive retrospective study was conducted, analyzing medical records of pediatric patients diagnosed with UI between 1990 and 2013.
  • Included patients had undergone RPC and IAPP and presented with clinical and pathological evidence of UI.
  • Data collected included sociodemographics, clinical presentation, diagnostic procedures, surgical techniques, and therapeutic interventions.

Main Results:

  • Eight pediatric patients (6 males) were diagnosed with UI after RPC; four had UC, two had total colonic aganglionosis (TCA), and two had complex anorectal malformations.
  • Symptoms included lower gastrointestinal bleeding, abdominal pain, abdominopelvic abscesses, and malabsorption with weight loss. Pathology revealed nonspecific inflammatory changes.
  • Medical treatments (antibiotics, corticosteroids, immunosuppressants) showed variable response; five patients required a new ileostomy, which resolved the ileitis, indicating diversion's efficacy.

Conclusions:

  • Ulcerative ileitis (UI) after colectomy is not exclusive to ulcerative colitis (UC) and can occur in children with conditions like total colonic aganglionosis and anorectal malformations.
  • The presence of a reservoir (pouch) is not essential for UI development, suggesting it may be a distinct entity.
  • Medical management of UI in children has limited effectiveness; surgical diversion of the fecal stream appears to be a successful treatment strategy.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
909
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
34
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
25
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
698